Latest News

Date Title Topic
31 Oct 2013 Therapy Matched to Oncogenic Drivers Improves Survival in Metastatic Lung Adenocarcionoma Personalised medicine - Lung and other thoracic tumours
30 Oct 2013 No Survival Benefit from Adding Cetuximab to Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer Lung and other thoracic tumours - Anticancer agents & Biologic therapy
30 Oct 2013 Annals of Oncology Press Release: Teenagers and Young Adults Diagnosed with Cancer are at Increased Risk of Suicide Cancer in Special Situations
29 Oct 2013 European Medicines Agency Issues Opinion that the Benefits of Deonosumab Do Not Outweigh its Risks in Patients with Castration-Resistant Prostate Cancer at High Risk of Spreading to the Bones Genitourinary cancers - Anticancer agents & Biologic therapy
28 Oct 2013 Castration Resistant Prostate Cancer; the Rise & Fall of Systemic Chemotherapy - Highlights from Recent Phase III Studies Genitourinary cancers
28 Oct 2013 European Medicines Agency Warning on Risk of Arterial Thrombosis with Ponatinib Anticancer agents & Biologic therapy
24 Oct 2013 International Agency for Research on Cancer Releases the Latest Global Cancer Trends in Five Continents Cancer prevention
23 Oct 2013 Pancreatic Cancer Patient Survival Increased with Adding nab-Paclitaxel to Gemcitabine Gastrointestinal cancers
22 Oct 2013 Mutational Landscape Identified in 12 Major Cancer Types Translational research
21 Oct 2013 Spanish Researchers Sequence Non-infiltrating Bladder Cancer Exome Genitourinary cancers - Translational research
17 Oct 2013 Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer Breast cancer
16 Oct 2013 Hitting Angiogenesis in Gastric Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
14 Oct 2013 Adjuvant Chemotherapy with Gemcitabine for Resected Pancreatic Cancer Gastrointestinal cancers
01 Oct 2013 ESMO @ ECC 2013: Addition of Trebananib to Paclitaxel Significantly Increases Progression-free Survival in Women with Recurrent Epithelial Ovarian Cancer Gynaecologic malignancies